Brief: Cerevel Therapeutics Appoints Ron Renaud As President And Chief Executive Officer And Reports First Quarter 2023 Financial Results

Cerevel Therapeutics Holdings

03/05/2023 12:27

Cerevel Therapeutics Holdings Inc  CERE.O :
    * CEREVEL THERAPEUTICS APPOINTS RON RENAUD AS PRESIDENT AND
CHIEF
EXECUTIVE OFFICER AND REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS
    * RON RENAUD TO SUCCEED TONY COLES, M.D. AS CEO, EFFECTIVE
JUNE
12, 2023
    * RENAUD WILL SUCCEED TONY COLES, WILL CONTINUE IN HIS ROLE
AS
CHAIRPERSON
    * QTRLY  LOSS PER SHARE $0.67

Source text for Eikon:  ID:nGNX2kNF2r 
Further company coverage:  CERE.O